Provided By GlobeNewswire
Last update: Feb 25, 2025
Ms. Lawver, former Chief Commercial Officer of Dexcom and Global Vice President at Johnson & Johnson responsible for billion-dollar Immunology and Cardiovascular & Metabolism Portfolios over her 20-year career
Read more at globenewswire.com